Open AccessClinical value of propranolol combined with oxaliplatin and tigio in concurrent chemoradiotherapy for locally advanced gastric cancer
Author(s) -
Yong Chen,
Yu Chen,
Zhibang Wang,
He Li,
Wang Yong-qi
Publication year - 2022
Publication title -
pakistan journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.316
H-Index - 30
eISSN - 1682-024X
pISSN - 1681-715X
DOI - 10.12669/pjms.38.5.5311
Subject(s) - medicine , oxaliplatin , mucositis , adverse effect , bone marrow suppression , incidence (geometry) , gastroenterology , group b , capecitabine , sensitization , cancer , chemoradiotherapy , group a , radiation therapy , oncology , chemotherapy , colorectal cancer , immunology , physics , optics
To investigate the clinical value of propranolol combined with oxaliplatin and tigio in concurrent chemoradiotherapy for locally advanced gastric cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom